Lv1
40 积分 2023-09-13 加入
Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
7小时前
求助中
Patient satisfaction scores with telemedicine in the neurosurgical population
6个月前
已完结
Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma
10个月前
已完结
CA Cancer J Clin. 2020 Jan;70(1):7-30
11个月前
已完结
A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer
11个月前
已关闭
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study
11个月前
已完结
Cadonilimab combined with chemotherapy with or without bevacizumab as first-line treatment in recurrent or metastatic cervical cancer (COMPASSION-13): a phase 2 study
1年前
已完结
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
1年前
已完结
皖公网安备34019202002308
